Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hck-IN-1 is a selective Nef-dependent Hck inhibitor (IC50s: 2.8 μM and >20 μM for Nef:Hck complex and Hck) with antiretroviral activity. Hck-IN-1 is a direct and wide HIV-1 Nef antagonist with an IC50 of 100-300 nM for wild-type HIV-1 replication.
説明 | Hck-IN-1 is a selective Nef-dependent Hck inhibitor (IC50s: 2.8 μM and >20 μM for Nef:Hck complex and Hck) with antiretroviral activity. Hck-IN-1 is a direct and wide HIV-1 Nef antagonist with an IC50 of 100-300 nM for wild-type HIV-1 replication. |
ターゲット&IC50 | HIV-1 (Nef):100-300 nM |
In vitro | Hck-IN-1 inhibits the replication of all eleven HIV-1 Nef chimeras (IC50s: ~ 300 nM in CEM-T4 cells) demonstrating that the compound is broadly active against HIV replication supported by a wide range of HIV-1 Nef proteins. Hck-IN-1 shows weak activity against other Src-family members in vitro, with IC50 values >20 μM for c-Src, Lck, and Lyn. B9 (1 μM; 8 days) completely inhibits Nef-dependent SFK activation at a concentration of 1.0 μM. Hck-IN-1 (0.1, 0.3, 1, 3 μM) also inhibits Nef-mediated enhancement of HIV-1 infectivity in a concentration-dependent manner in the reporter cell line, TZM-bl. |
分子量 | 402.81 |
分子式 | C16H11ClN6O3S |
CAS No. | 1473404-51-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 12.5 mg/mL (31.03 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hck-IN-1 1473404-51-1 Angiogenesis Microbiology/Virology Proteases/Proteasome Tyrosine Kinase/Adaptors HIV Protease Hck Src anti-retroviral Nef diphenylpyrazolo Hck IN 1 Nef:Hck Nef-dependent replication Inhibitor HIV inhibit HckIN1 Human immunodeficiency virus Asn126 inhibitor